Ads
related to: pfe stock zacks price forecastsignup.chaikinanalytics.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Goldman forecasts for 2025 revenues of $64.9 billion and EPS of $3.13, which compares to consensus estimates of $63.2 billion and $2.89, respectively. ... Price Action: PFE stock is down 0.39% at ...
Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The falling share price has pushed the stock's dividend yield to nearly 6%. There are signs though that the reduced-performance pain may be nearing an end. Catalysts in the drug production ...
Price Action: PFE stock is down 0.77% at $25.62 at last check Tuesday. Read Next: Keros Therapeutics’ Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst.